Overview

A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain

Status:
Terminated
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate two different treatments in subjects with chronic pancreatitis, exocrine pancreatic insufficiency and chronic abdominal pain.
Phase:
Phase 1
Details
Lead Sponsor:
Eurand Pharmaceuticals
Forest Laboratories
Collaborator:
University of Florida
Treatments:
Pancreatin
Pancrelipase